24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
Chinese Scientists Cut Local Numbers of Dangerous Mosquito by 94%Health Tip: Recognizing Heat ExhaustionInsect Stings Are Just a Buzzkill for Most FolksDisinfectants Can't Stop This Dangerous Hospital GermHealth Tip: Working in Extreme HeatHealth Tip: Diarrhea in KidsHow to Protect Your DNA for Big Health BenefitsNewer Lung Cancer Screening Saves More LivesHigh Blood Pressure, 'Bad' Cholesterol Risky for Young, TooSummer Can Be Hard on Your HearingMany Pneumonia Patients Get Too Many AntibioticsAdopt a Diet That's Good for Your GutAHA News: 5 Threats to Heart Health You May Not Be Aware OfTongue, Lip Snip Surgeries May Be Overused in U.S. NewbornsHealth Tip: Foods With LactoseHealth Tip: Living With Celiac DiseaseMore Evidence Fried Food Ups Heart Disease, Stroke RiskBrain Injury Often a Devastating Side Effect of Domestic ViolenceNew Migraine Drug Might Help When Other Meds Don'tXpovio With Dexamethasone Approved for Refractory Multiple MyelomaPoor Social Life Could Spell Trouble for Older Women's BonesIs Your Mattress Releasing Toxins While You Sleep?Zika's Damage Continues in Children Infected Before BirthCDC Warns of Start to 'Season' for Mysterious Paralyzing Illness in KidsShould You Try Allergen Immunotherapy?Dangerous UTIs Can Follow Hospital Patients HomeMore Evidence Supplements Won't Help the Heart'Semi-Slug' Is Spreading a Lethal Parasite in HawaiiAHA News: 'Surprising' Lack of Progress on Heart Disease in Younger AdultsSmall Vessel Disease Leaves Patients Vulnerable to Leg AmputationHealth Tip: Eating Out If You Have a Food AllergyHow to Create a Diet That Lowers Your CholesterolHow Protect Against Short- and Long-Term Sun DamageSurgeons Give 13 Paralyzed Adults Hand, Arm MovementIt's Mosquito Season: Here's How to Protect YourselfConcussion Recovery Isn't the Same for Every Football PlayerOften Feel Bloated? One Ingredient May Be to BlameFor Many, Pot Is Now an Alternative to Opioids or Sleep MedsSurgery Helps Babies Missing a Heart Chamber Survive, But Problems LingerAnti-Vaccine Movement a 'Man-Made' Health Crisis, Scientists WarnCan Stem Cells Be the Cure for Baldness?Cancer Risk Rises After Iodine Rx for Overactive Thyroid: StudyGut Bacteria Supplements Might Boost Obese People's HealthEye Injuries From Fireworks in U.S. Have Nearly DoubledHealth Tip: Swallowing ProblemsMedtronic Recalls Some Insulin Pumps as FDA Warns They Could Be HackedAir Pollution Bad News for Your Blood PressureFDA Approves First Drug for Sinusitis With Nasal PolypsInfections, Especially UTIs, May Be Triggers for StrokesCould Heavier Folks Be at Lower Risk for ALS?
Questions and AnswersLinks
Related Topics

Diabetes

Xpovio With Dexamethasone Approved for Refractory Multiple Myeloma


HealthDay News
Updated: Jul 10th 2019

new article illustration

TUESDAY, July 9, 2019 (HealthDay News) -- Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma, the U.S. Food and Drug Administration announced last week.

The drug combination was granted accelerated approval for patients whose disease remains resistant to other treatments, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

Approval was based on data from 83 patients with relapsed refractory multiple myeloma who received Xpovio and dexamethasone. Researchers found an overall response rate of 25.3 percent at the end of the study. Median time to first response was four weeks and ranged from one to 10 weeks. Median response duration was 3.8 months. The FDA notes that approval was also based on information from an ongoing, randomized trial in patients with multiple myeloma, but additional clinical trials are required to verify the clinical benefit of Xpovio.

Commonly reported side effects with the drug combination include leukopenia, low neutrophil count, neutropenia, thrombocytopenia, and anemia. Vomiting, nausea, fatigue, diarrhea, fever, decreased appetite, weight loss, constipation, upper respiratory tract infections, and hyponatremia were also reported. Clinicians should monitor patients being treated with Xpovio and dexamethasone for low blood counts, platelets, and sodium levels; they should optimize patients' hydration status, blood counts, and other medications to avoid dizziness or confusion. Patients should be advised to not take Xpovio with medications that could cause dizziness or confusion.

Approval of Xpovio was granted to Karyopharm Therapeutics.

More Information